# Safety and Efficacy of Addition of Structured Lipids in Starter Formulas

> **NCT02332967** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 488 (actual)

## Conditions studied

- Healthy Newborn Infants

## Interventions

- **OTHER:** Whey predominant starter formula
- **OTHER:** Whey predominant starter formula + 40% palmitic acid
- **OTHER:** Whey predominant starter formula + 50% palmitic acid

## Key facts

- **NCT ID:** NCT02332967
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2012-02
- **Final completion:** 2012-09
- **Target enrollment:** 488 (ACTUAL)
- **Last updated:** 2015-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02332967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02332967, "Safety and Efficacy of Addition of Structured Lipids in Starter Formulas". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02332967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*